Skip to main content
. 2012 Jan 28;3(1):22–30. doi: 10.18632/oncotarget.437

Figure 2. Sonographic recording of the popliteal left metastasis during rituximab therapy.

Figure 2

The metastasis substantially shrinks during therapy from approximately 722 mm2 to 135 mm2, i.e., a reduction by 80%; note that the blood vessel immediately under the metastasis showed nearly the same diameter in these projections.